Exclusive | Netflix exec goes ballistic after being fired for stunning 'trust exercise' confession at retreat: suit

A Netflix executive was terminated after disclosing medically prescribed ketamine use during a trust‑exercise retreat. The employee, who held a role valued at $1.1 million, told co‑workers about the drug use, prompting the company to end his employment. The confession occurred at a company‑organized retreat designed for team building, and the disclosure was described as part of a ‘trust exercise’. Following the dismissal, the former executive filed a lawsuit alleging wrongful termination. Financial Express and NDTV noted that the suit claims the firing violated his rights after a medically prescribed prescription was disclosed.

Benzinga and the New York Post also covered the legal filing, highlighting the executive’s demand for reinstatement and compensation. The filing also seeks damages for reputational harm. Media coverage has focused on the intersection of workplace drug policies and mental‑health treatment. The case remains unresolved, with the lawsuit pending in court. No settlement has been announced, and Netflix has not publicly commented on the allegations beyond confirming the termination.

Observers note that further legal filings may clarify how companies handle disclosed medical treatments in employment decisions. Stakeholders will watch for any corporate policy updates following the court’s ruling. The dispute is expected to evolve as court proceedings advance.